相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Widdrol activates DNA damage checkpoint through the signaling Chk2-p53-Cdc25A-p21-MCM4 pathway in HT29 cells
Hee Jung Yun et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Clinical trials of resveratrol
Ketan R. Patel et al.
RESVERATROL AND HEALTH (2011)
Endocytosis of Resveratrol via Lipid Rafts and Activation of Downstream Signaling Pathways in Cancer Cells
Didier Colin et al.
CANCER PREVENTION RESEARCH (2011)
New Topoisomerase I mutations are associated with resistance to camptothecin
Celine Gongora et al.
MOLECULAR CANCER (2011)
Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: Consequences in bioavailability and activities
Dominique Delmas et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Ole Vang et al.
PLOS ONE (2011)
Pleiotropic mechanisms facilitated by resveratrol and its metabolites
Barbara Calamini et al.
BIOCHEMICAL JOURNAL (2010)
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria A. Brown et al.
CANCER RESEARCH (2010)
Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
Ketan R. Patel et al.
CANCER RESEARCH (2010)
The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Paul A. Kroon et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites
Juma Hoshino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Resveratrol bioavailability and toxicity in humans
Charles-Henry Cottart et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions
Laurent Camont et al.
ANALYTICA CHIMICA ACTA (2009)
Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells
Didier Colin et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Pharmacokinetics of Trans-resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects
Teresa Nunes et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
Luis Almeida et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Dietary phenolics: chemistry, bioavailability and effects on health
Alan Crozier et al.
NATURAL PRODUCT REPORTS (2009)
Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions
M. Reis-Sobreiro et al.
ONCOGENE (2009)
Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53-and-Nbs1-dependent manner
Susanne Andrea Gatz et al.
CARCINOGENESIS (2008)
Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells
Anna-Kristina Marel et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells
Elke H. Heiss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Resveratrol in human hepatoma HepG2 cells: Metabolism and inducibility of detoxifying enzymes
Allan Lancon et al.
DRUG METABOLISM AND DISPOSITION (2007)
Resveratrol as a chemopreventive agent:: A promising molecule for fighting cancer
D Delmas et al.
CURRENT DRUG TARGETS (2006)
Time-dependent resveratrol-mediated mRNA and protein expression associated with cell cycle in WR-21 cells containing mutated human c-Ha-ras
LF Young et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells
A Tyagi et al.
CARCINOGENESIS (2005)
Metabolism and bioavailability of trans-resveratrol
E Wenzel et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats
E Wenzel et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Resveratrol: Preventing properties against vascular alterations and ageing
D Delmas et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol
S Fulda et al.
ONCOGENE (2004)
High absorption but very low bioavailability of oral resveratrol in humans
T Walle et al.
DRUG METABOLISM AND DISPOSITION (2004)
Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells
D Delmas et al.
ONCOGENE (2004)
Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells
D Delmas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line
HY Lin et al.
JOURNAL OF UROLOGY (2002)
Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells
D Bernhard et al.
CELL DEATH AND DIFFERENTIATION (2000)
分享论文
